Sunday, October 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Applied Therapeutics Reports Disappointing Q4 Financial Results

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Applied Therapeutics (NASDAQ: APLT) unveiled its Q4 financial results on March 6, 2024, at 07:00 AM, revealing some important details:

– Earnings: The company fell short of expected earnings by -74.0%, with an EPS of $-0.4 compared to the projected $-0.23.
– Revenue: Revenue saw a decrease of $667 thousand from the same period in the previous year.
– Previous Performance: In the previous quarter, Applied Therapeutics missed EPS expectations by $0.21, resulting in a 2.0% decline in share price the following day.

For more insights and updates on Applied Therapeutics’ financial performance, investors can visit their investor relations page.

APLT Stock Performance on March 6, 2024: Trading in Middle of 52-Week Range

On March 6, 2024, APLT stock showed mixed performances as it traded in the middle of its 52-week range and above its 200-day simple moving average. The stock opened at $6.43, which was $0.26 higher than its previous close. However, throughout the trading day, the price of APLT shares decreased by $0.05, resulting in a 0.81% drop from the previous close.

APLT Stock Performance Analysis: Mixed Results on March 6, 2024

On March 6, 2024, APLT stock experienced mixed performances based on the available data from CNN Money. The company’s total revenue information was not available at the time, making it difficult to assess its overall financial health. However, looking at the net income and earnings per share figures, we can gain some insights into APLT’s recent performance.

APLT reported a net income of -$82.51 million over the past year, which represents a 21.86% increase compared to the previous year. However, the net income for the third quarter of the year was -$42.37 million, indicating a 43.25% decrease from the previous quarter. This significant decrease in net income from the previous quarter could be a cause for concern among investors.

Similarly, the earnings per share (EPS) figures for APLT also showed a mixed performance. The EPS for the past year was reported at -$2.18, marking a 47.12% increase from the previous year. However, the EPS for the third quarter of the year was -$0.47, reflecting a 24.88% decrease from the previous quarter. This decline in EPS from the previous quarter could indicate potential challenges for the company in maintaining profitability.

Overall, APLT stock performances on March 6, 2024, showed a mixed picture with an increase in net income and EPS compared to the previous year but a significant decrease from the previous quarter. Investors may need to closely monitor APLT’s financial performance and future earnings reports to assess the company’s long-term growth prospects and investment potential.

Tags: APLT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Automotive Trading online

Challenges and Concerns for Nio Analysts Slash Price Targets

Finances-and-tech

Analysts Evaluation of Solo Brands Mixed Opinions and Price Targets

Ecommerce Stock Market Today

Title Appreciation for Detailed Postage Policy

Recommended

Analyst Initiates Coverage on Summit Hotel Properties with Peer Perform Rating

2 years ago
Chatbots in finance

Unveiling the Future: How AI Chatbots Are Transforming Customer Engagement in Finance

2 years ago
Broadcom Stock

Broadcom Emerges as Silent AI Contender with Major OpenAI Partnership

1 month ago
Biopharmaceutical Stock Market Today (1)

Pfizer Inc Prepares for Fourth Quarter Financial Results Amidst Stock Fluctuations and Dividend Announcement

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Space Sector Soars as Japan Backs Rocket Lab’s Ascent

FlexShopper Faces Critical Survival Deadlines

Ocuphire Pharma: A Speculative Surge Defying Financial Fundamentals

Semiconductor Stock Surges Amid Retail Trading Frenzy

Hydrofarm Navigates Turbulent Waters Amid Financial Restructuring

Rockwell Medical Shares Plunge Amid Intensifying Sell-Off

Trending

Enovix Corporation Stock
Analysis

Enovix Shares Approach Critical Milestone

by Felix Baarz
October 12, 2025
0

The upcoming week represents what could be the most significant period in Enovix's corporate history. Market participants...

Express Stock

Shareholder Wipeout: Express Equity Faces Complete Loss in Liquidation

October 12, 2025
NRX Pharmaceuticals Stock

NRX Pharma Shares Plunge Following Corporate Update

October 12, 2025
Rocket Lab USA Stock

Space Sector Soars as Japan Backs Rocket Lab’s Ascent

October 12, 2025
FlexShopper Stock

FlexShopper Faces Critical Survival Deadlines

October 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Enovix Shares Approach Critical Milestone
  • Shareholder Wipeout: Express Equity Faces Complete Loss in Liquidation
  • NRX Pharma Shares Plunge Following Corporate Update

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com